Address
Hatteras Venture Partners II
280 S Mangum St
Suite 510
Durham, NC 27701
United States
Phone
Website
KANDO id: 110884
Fund terms
Fund manager
Vintage
2004
Fund type
Country from which managed
United States
Funding rounds
Investment activity status
Active investor
Selected investments
Displaying 1 - 16 of 16| Company | Profile | Country | Funding | ||
|---|---|---|---|---|---|
![[current-page:title] logo](/sites/default/files/styles/icon/public/default_images/_no-logo.png?itok=AH4pbDYM){kind=icon}
|
Asthmatx Inc | N/A | |||
|
|
BRAHMS GmbH | N/A | |||
|
|
Broncus Technologies Inc | Developer of interventional bronchoscopy devices for the treatment of chronic lung diseases. | N/A | ||
|
|
Delenex Therapeutics AG | N/A | |||
|
|
ESBATech AG | Switzerland based Biomedical Research Unit of Alcon | N/A | ||
|
|
Kolltan Pharmaceuticals Inc | Oncology therapeutics company, develops monoclonal antibody drugs targeting receptor tyrosine kinases. | N/A | ||
|
|
Lux Biosciences Inc | Clinical stage biotechnology company specializing in the development and commercialization of innovative medications for serious ophthalmic diseases. | N/A | ||
|
|
Micardia Corp | N/A | |||
|
|
Mpex Pharmaceuticals Inc | N/A | |||
|
|
mtm laboratories AG | N/A | |||
|
|
Nabriva Therapeutics AG | N/A | |||
|
|
Nereus Pharmaceuticals Inc | N/A | |||
|
|
Newron Pharmaceuticals SpA | N/A | |||
|
|
Precimed Group | A leading technology-driven supplier to the orthopaedic industry | N/A | ||
|
|
Zosano Pharma Inc | N/A | |||
|
|
Anthera Pharmaceuticals Inc | N/A |